Black Diamond Therapeutics, Inc. Annual Return On Assets in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Black Diamond Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2020 to 2023.
  • Black Diamond Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -49.7 %, a 13.8% increase year-over-year.
  • Black Diamond Therapeutics, Inc. annual Return On Assets for 2023 was -56.2 %, a 16.4% decline from 2022.
  • Black Diamond Therapeutics, Inc. annual Return On Assets for 2022 was -48.3 %, a 7.96% decline from 2021.
  • Black Diamond Therapeutics, Inc. annual Return On Assets for 2021 was -44.7 %, a 131% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -56.2 -7.93 -16.4% Jan 1, 2023 Dec 31, 2023
2022 -48.3 -3.56 -7.96% Jan 1, 2022 Dec 31, 2022
2021 -44.7 -25.4 -131% Jan 1, 2021 Dec 31, 2021
2020 -19.4 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.